| Prev Close | 202.39 |
| Open | 205.00 |
| Day Low/High | 203.41 / 213.56 |
| 52 Wk Low/High | 118.50 / 224.64 |
| Volume | 1.59M |
| Avg Volume | 2.51M |
Cigna Corp. (CI)
209.41
7.00
3.50
NYSE : Health Services
| Exchange | NYSE |
| Shares Outstanding | 368.98M |
| Market Cap | 74.30B |
| EPS | 13.60 |
| P/E Ratio | 14.16 |
| Div & Yield | 0.04 (0.02%) |
Latest News
China Reduces Tariffs, 20 Year Treasury Bonds, Pricey Peloton: Market Recon
This move by Beijing comes on top of massive injections of liquidity into that nation's financial system earlier this week.
Drug Companies Are a Political Football, Trading Amgen: Market Recon
The nation enters an electoral season. The drug companies for the most part, have no friends on either side of the aisle.
Fed's Action, Consumer Remains Robust, Unimpressive Twilio: Market Recon
I do think that this Fed Chair has learned to be cautious, in reflection of the policy errors made in late 2018.
Timing and Psychology Are Everything When Bargain Hunting
When you're the most bummed out about how much you've lost, so is everybody else, and that's when they're willing to part with even the best stocks at really low prices.
Cigna Appears a Healthy Investment
With a discounted share price and health coverage proposals among politicians, there are multiple ways to play Cigna.
Jim Cramer: Welcome to a Market Filled With Fear
The impact of Elizabeth Warren is pretty much everywhere Thursday.
Powell's Verbal Fouls, an Equity Beatdown and Silence of the Lam: Market Recon
The Fed chairman's news conference threw markets for a loop with hawkish words that did not support the Fed's dovish actions.
A New Brand of Protest Emerges in Hong Kong
A Japanese drink-maker, as well as Cigna and Yum! Brands' Pizza Hut, have been swept into the 'product politics' battle between pro-democracy demonstrators and pro-Mainland authorities.
European Debt Markets, Uninverting Curve, Facebook's Libra, Trading Costco
This matters: Why the sudden 'weakness' across European debt markets?
Cigna Looks Poised for a Rally to Break 6-Month Decline
The health services and insurance company appears ready to rally to the low $180-area.
Watching This Bearish Chart Pattern, and Why I Like Twilio Here: Market Recon
For the major indices, Wednesday offered up a dangerous bearish reversal.
3 Top Healthcare Stocks Ripe For the Buying
I've spotlighted three blue-chip companies with stock prices that are at ridiculously low valuations right now.
Chart of the Day: UNH's Universal Healthcare Comments Sting Sector
The free press that the progressive push for Medicare got on Tuesday morning is hurting the healthcare sector.
UnitedHealth Group Receives Booster Shot From Healthy Earnings, Outlook
The health benefit giant's fundamentals are good, but there are more symptoms to consider for a proper examination.
The Global Macro-Economic Picture, China Watch, Keys to Amazon: Market Recon
The real takeaway for AMZN for me, and the main reason that I am even in the name on a semi-permanent basis, is AWS.
Jim Cramer: Why Wouldn't You Own Apple Stock?
Has the sun set on what was the greatest wealth creator of any company when the stock traded north of a trillion dollars? No.
Real Money Post Industrial Average Outperformed the Market in 2018
The RMPIA index was up for the year, while the S&P 500, DJIA, Russell 2000 and Nasdaq all finished 2018 in the red.
Jim Cramer: What to Buy in This Treacherous Market
Look for the big-cap stocks that only come in on tough days -- and take advantage of their weakness at the open.
Jim Cramer: Why the Market Did What It Did Today and What Can Happen Tomorrow
Now for those of you haven't voted, please go and do so and don't vote this stuff just invest in it!
Markets Are Headed For a More Difficult Environment: Market Recon
Santa is on his way... A lot of pressure on the jolly fellow this year.
Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter
Straying from these names could land you in quicksand as the 4th quarter begins.
Jim Cramer: Valuations Now Have No Relation to Common Sense
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
Jim Cramer: These CEOs Deserve the Benefit of the Doubt
Sometimes you gotta have faith, but you also have to be a little more skeptical.
Does the Stock Market Deserve to Be Near Records?
Stock prices continue to head higher, but does the rally make any sense? Tesla shares lose momentum. Carl Icahn declares war on Cigna.
2 Ways to Play Nvidia Into Earnings: Market Recon
Go long on strong fundamentals, or try this options strategy.
